-
EP1270595
European procedure
Extract from the Register of European Patents
EP Citations: EP1270595
| Cited in | Search | Type: | Non-patent literature | Publication information: | No further relevant documents disclosed | Cited in | International search | Type: | Patent literature | Publication No.: | WO0067791
[XP] (APPLIED RESEARCH SYSTEMS et al.) [XP] | Type: | Patent literature | Publication No.: | WO0042074
[XP] (MILLENIUM PHARMACEUTICALS INC et al.) [XP] | Type: | Patent literature | Publication No.: | WO9710354
[A] (KYOWA HAKKO KOGYO KK et al.) [A] | Type: | Patent literature | Publication No.: | WO0000219
[A] (CHUGAI PHARMACEUTICAL CO LTD et al.) [A] | Type: | Patent literature | Publication No.: | WO9925380
[A] (UNIV KENTUCKY RES FOUND et al.) [A] | Type: | Non-patent literature | Publication information: | [X] POWER C.A. ET AL.: "Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line", J. BIOL. CHEM., vol. 270, no. 33, 1995, pages 19495 - 19500, XP002942184 [X] | DOI: | http://dx.doi.org/10.1074/jbc.270.6.2716 | Type: | Non-patent literature | Publication information: | [Y] JONES D. ET AL.: "Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-hodgkin lymphoma", BLOOD, vol. 96, no. 2, July 2000 (2000-07-01), pages 685 - 690, XP002942185 [Y] | Type: | Non-patent literature | Publication information: | [A] MUELLER B.M. ET AL.: "enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody", J. IMMUNOL., vol. 144, no. 4, 1990, pages 1382 - 1386, XP002942186 [A] | Type: | Non-patent literature | Publication information: | [A] RIECHMANN L. ET AL.: "reshaping human antibodies for therapy", NATURE, vol. 332, 1988, pages 323 - 327, XP002942187 [A] | DOI: | http://dx.doi.org/10.1038/332323a0 | Type: | Non-patent literature | Publication information: | [A] VAN DEN BERG, A. ET AL.: "High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in hodgkin's lymphoma", AM. J. PATHOL., vol. 154, no. 6, 1999, pages 1685 - 1691, XP002942188 [A] | Type: | Non-patent literature | Publication information: | [A] D'AMBROSIO D. ET AL.: "Cutting edge: selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells", J. IMMUNOL., vol. 161, 1998, pages 5111 - 5115, XP002942189 [A] | Type: | Non-patent literature | Publication information: | [A] BONECCHI R. ET AL.: "Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s", J. EXP. MED., vol. 187, no. 1, 1998, pages 129 - 134, XP002942190 [A] | DOI: | http://dx.doi.org/10.1084/jem.187.1.129 | Type: | Non-patent literature | Publication information: | [A] YOUN B.-S. ET AL.: "Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C-C chemokine receptor, CCR-4", BLOOD, vol. 89, no. 12, 1997, pages 4448 - 4460, XP002942191 [A] | Type: | Non-patent literature | Publication information: | [A] FRADE J.M.R. ET AL.: "The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection", J. CLIN. INVEST., vol. 100, no. 3, 1997, pages 497 - 502, XP002942192 [A] | DOI: | http://dx.doi.org/10.1172/JCI119558 | Cited in | Examination | Type: | Non-patent literature | Publication information: | JULIAN DAVIES, LUTZ RIECHMANN: "Affinity improvement of single antibody VH domains: residues in all three hypervariable regions affect antigen binding", IMMUNOTECHNOLOGY, vol. 2, 1996, pages 169 - 179, XP004070292 | DOI: | http://dx.doi.org/10.1016/S1380-2933(96)00045-0 | Type: | Non-patent literature | Publication information: | Declaration of Mr. Koike, pages 1-7; figures 1 and 2 | Type: | Non-patent literature | Publication information: | "Disease Information", Retrieved from the Internet | Type: | Non-patent literature | Publication information: | "The Leukemia & Lymphoma Society Clinical Trial Service", Retrieved from the Internet | Type: | Non-patent literature | Publication information: | "Blood Cancer Transplants: Peripheral blood cells better than bone marrow", Retrieved from the Internet | Type: | Non-patent literature | Publication information: | "NCI Director von Eschenbach hails the "Vital Contribution" of ASH in Address at Annual Meeting", Retrieved from the Internet | Type: | Non-patent literature | Publication information: | "Leukemia and Lymphoma Society", Retrieved from the Internet | Type: | Non-patent literature | Publication information: | Abstracts from the ASH meeting December 2006; pages 1-8, abstracts #163, #207, #856 |